The drug could cost women as much as $400 per month

Valeant Pharmaceuticals agreed to pay about $1 billion (€895 million) in cash for Sprout Pharmaceuticals, the US pharmaceutical group that this week r(...)

The drug flibanserin, which is marketed under the trade name Addyi, nicknamed “female Viagra”.

It has been dubbed the “female Viagra” and this week it became the first drug for treating loss of libido in women to win approval in the US. The deci(...)

The drug flibanserin, under the trade name Addyi, nicknamed “female Viagra” is shown in this undated Sprout Pharmaceuticals handout photograph released on Tuesday. Photograph: Sprout Pharmaceuticals/Reuters. 1:19

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous l(...)

Without FDA approval, no drug or medical device can access what is by some distance the world’s largest market for pharma and medtech. Photograph: Roel Smart/Getty Images/iStockphoto

In what was truly a case of David vs Goliath, Irish pharma minnow Amarin comprehensively saw off the might of the US drug regulator, the Food and Drug(...)

Amarin chief executive and president  John Thero. Photograph: Cyril Byrne / THE IRISH TIMES

A small one-product Irish pharmaceutical company has secured a landmark victory over the US drugs regulator in a New York court. US district ju(...)

 Bruce Cozadd, CEO of Jazz Pharmaceuticals. Photograph: Dara Mac Dónaill

It’s a stock market darling, delivering recurring double-digit revenue growth, a growing pipeline, regularly listed among prime M&A targets in the(...)

Alkermes president Shane Cooke. Photograph: Kate Geraghty/ The Irish Times

Alkermes, the Irish drug company specialising in drugs for conditions affecting the central nervous system has upgraded its forecasts for the full yea(...)

Profits at Trinity Biotech fell by 37 in its second quarter, as the Irish medical diagnostic firm reported a decline in HIV revenues in Africa.

Profits at Trinity Biotech fell by 37 in its second quarter, as the Irish medical diagnostic firm reported a decline in HIV revenues in Africa. In th(...)

LDL cholesterol causes “furring” of the arteries that supply blood to the heart and the brain, which puts those affected at greater risk of heart attack and stroke. Photograph: JB Reed/Bloomberg News

A novel class of cholesterol-lowering drug could be available to Irish patients by the end of the year, following the approval of the first of the new(...)

Richard Pops, chief executive  of Alkermes at their Dublin offices. Photograph: Aidan Crawley

Revenue at Irish drug group Alkermes jumped almost 24 per cent in the first three months of the year, to $161.2 million, ahead of analyst expectations(...)